Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 01-2010 | 10-2009 | 07-2009 | 04-2009 | |
| Sales | 531 | 268 | 144 | 0 | 167 |
| Cost of Goods | 602 | 520 | 442 | N/A | 449 |
| Gross Profit | -71 | -251 | -298 | N/A | -282 |
| Operating Expenses | 1,269 | 1,011 | 899 | 0 | 923 |
| Operating Income | -738 | -742 | -755 | N/A | -755 |
| Interest Expense | 2 | 3 | 1 | 0 | 2 |
| Pre-tax Income | -740 | -745 | -756 | 0 | -757 |
| Net Income Continuous | -740 | -745 | -756 | N/A | -757 |
| Net Income | $-740 | $-745 | $-756 | $N/A | $-757 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.08 | N/A | -0.09 |
| EPS Basic Continuous Ops | -0.07 | -0.07 | -0.08 | N/A | -0.09 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.08 | N/A | -0.09 |
| EPS Diluted Continuous Ops | -0.07 | -0.07 | -0.08 | N/A | -0.09 |
| EBITDA(a) | $-723 | $-728 | $-741 | $N/A | $-723 |